Marex Group plc Ordinary Shares
NASDAQ:MRXFinancial - Capital Markets
+$0.93 today
- Market cap
- $4.61B
- Beta
- -0.00
- P/E (TTM)
- 14.5
- EPS (TTM)
- $4.32
- Dividend yield
- 0.98%
Volume 0.83M
Average 1.11M
MRX Total Liabilities
Everything the company owes to creditors and other parties.
Marex Group plc Ordinary SharesNASDAQ: MRX
Total Liabilities · Q2 FY2026 · quarter ended Jun 2026
Total liabilities rises 33.8% from a year ago
Total liabilities stood at $40.26B at the end of Q2 FY2026, up 33.8% from a year earlier. Over 3 fiscal years it compounded at +30.4% a year.
Context
- Total liabilities amounted to 95.6% of total assets at the end of Q2 FY2026, down 0.9 pp from a year earlier.
- Total liabilities increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total liabilities keeps rising in the next quarterly balance sheet after a +33.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 33.41B USD
- Year-over-year change
- +43.2%
- 4-year CAGR
- +62.5%
| Period | Period end | Total Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 33.41B | +43.2% |
| FY2024 | 2024-12-31 | 23.34B | +38.6% |
| FY2023 | 2023-12-31 | 16.84B | +11.7% |
| FY2022 | 2022-12-31 | 15.07B | +214.7% |
| FY2021 | 2021-12-31 | 4.79B | — |
Total Liabilities vs competitors
How MRX compares with its peers on the latest reported figures
- MRX's Jun 2026 total liabilities of $40.26B is the 4th highest of the 10 companies compared; the peer median is $15.38B.
- Its year-over-year change of +33.8% is the 3rd highest of 10, against a peer median of +13.5%.
- Total liabilities amounts to 95.6% of total assets for MRX, versus a peer median of 78.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $2.06T | +22.8% | +8.3% | 94.3% | |
| Aug 2026 | $70.55B | +19.9% | +17.1% | 86.8% | |
| Jun 2026 | $51.2B | +58.6% | +31.7% | 94.7% | |
MRXMarex Group plc Ordinary Shares | Jun 2026 | $40.26B | +33.8% | +30.4% | 95.6% |
| Jun 2026 | $38.9B | +13.5% | +3.8% | 86.6% | |
| Sep 2026 | $15.38B | -17.4% | +8.6% | 56.2% | |
| Sep 2026 | $4.5B | -3.9% | +11.7% | 78.2% | |
| Sep 2026 | $985.82M | +58.1% | +7.3% | 43.3% | |
| Jun 2026 | $912.69M | -31.4% | +11.9% | 11.1% | |
| Sep 2026 | -$117.44B | -109.4% | +6.6% | 6.9% | |
| Peer median (excluding MRX) | $15.38B | +13.5% | +8.6% | 78.2% | |
Competitors are the stored peer set for MRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 712M | 910.1M | 1.48B | 2.56B | 6.38B |
| Short-term Investments | 46.3M | 2.31B | 3.25B | 2.66B | 7.08B |
| Net Receivables | 2.17B | 9.04B | 7.71B | 9.55B | 11.07B |
| Inventory | 80.1M | 35.8M | 163.4M | 35.8M | 0 |
| Other Current Assets | 1.11B | 2.69B | 4.05B | 8.52B | 0 |
| Total Current Assets | 4.12B | 15.35B | 16.94B | 23.83B | 24.53B |
| Property, Plant & Equipment (Net) | 20.9M | 45.5M | 57.2M | 80.7M | 110.9M |
| Goodwill | 208.9M | 155.5M | 163.6M | 176.5M | 237.4M |
| Intangible Assets | 21.5M | 25.6M | 56M | 56.5M | 98M |
| Long-term Investments | 84.8M | 22M | 77M | 77.5M | 5.89B |
| Tax Assets | 4M | 7.6M | 21.4M | 46.7M | 30.6M |
| Other Non-current Assets | 799.7M | 133.5M | 300.4M | 46.1M | 3.78B |
| Total Non-current Assets | 1.14B | 389.7M | 675.6M | 484M | 10.15B |
| Total Assets | 5.26B | 15.74B | 17.61B | 24.31B | 34.68B |
| Account Payables | 3.29B | 6.65B | 4.92B | 7.74B | 11.78B |
| Short-term Debt | 1.13B | 5.22B | 4.43B | 4.58B | 7.81B |
| Tax Payables | 2.1M | 8.9M | 18M | 51.8M | 0 |
| Deferred Revenue | 0 | 1M | 500K | 2.4M | 0 |
| Other Current Liabilities | 200.3M | 2.42B | 4.65B | 7.41B | (12.96B) |
| Total Current Liabilities | 4.63B | 14.56B | 15.88B | 21.78B | 7.75B |
| Long-term Debt | 136.6M | 472.1M | 907.9M | 1.48B | 2.33B |
| Deferred Tax Liabilities | 3.2M | 100K | 3.7M | 4.5M | 14M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 23.23B |
| Total Non-current Liabilities | 156.8M | 504.3M | 951M | 1.56B | 25.66B |
| Total Liabilities | 4.79B | 15.07B | 16.84B | 23.34B | 33.41B |
| Common Stock | 100K | 100K | 100K | 100K | 100K |
| Retained Earnings | 346.6M | 455.3M | 555.3M | 722.4M | 982M |
| Accumulated OCI | (3.3M) | (1.7M) | (1.6M) | (22.6M) | 15.4M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | (200K) |
| Total Equity | 477.7M | 677.7M | 775.9M | 976.9M | 1.26B |
| Total Debt | 1.29B | 5.73B | 5.39B | 6.14B | 10.24B |
| Net Debt | 578.1M | 4.82B | 3.9B | 3.58B | 3.86B |
Marex Group plc Ordinary Shares
NASDAQ:MRX
Intrinsic Alpha fair value
Locked
Current Price
$64.10
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.